Literature DB >> 1008348

Pulmonary aspiration of gastric contents.

L J Bynum, A K Pierce.   

Abstract

A retrospective analysis of 50 patients who had been observed to aspirate gastric contents was performed to define better the course of patients with this syndrome. The patients invariably had a disturbance of consciousness, most commonly due to sedative drug overdose or general anesthesia. The onset of clinical signs occurred prompty after aspiration and tended to be similar in all patients, irrespective of their subsequent course or outcome. These findings usually included fever, tachypnea, diffuse rales, and serious hypoxemia. Cough, cyanosis, wheezing, and apnea were each seen in approximately one third of the cases. Apena, shock, and early severe hypoxemia were particularly ominous events. Initial roentgenograms revealed diffuse or localized alveolar infiltrates, which progressed during the next 24 to 36 hours. Subsequent clinical courses followed 3 patterns: 12 per cent of the patients died shortly after aspiration; 62 per cent had rapid clinical and radiologic improvement, with clearing, on average, within 4.5 days; 26 per cent demonstrated rapid improvement, but then had clinical and radiographic progression associated with recovery of bacterial pathogens from the sputum and a fatal outcome in more than 60 per cent. Treatment from the outset by adrenocortical steroids or antimicrobial agents had no demonstrable effect on the outcome. The clinical features of aspiration of gastric contents are characteristic and distinguish it from other forms of aspiration-related lung disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008348     DOI: 10.1164/arrd.1976.114.6.1129

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  18 in total

1.  Severe gastroparesis causing postoperative respiratory complications in a heart-lung recipient.

Authors:  Yiqin Tao; Zhongya Yan; Jiming Sha; Zhengyan Zhu; Hong Lei
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

2.  A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia.

Authors:  Philippe Jaoude; Jessica Badlam; Anil Anandam; Ali A El-Solh
Journal:  Intern Emerg Med       Date:  2012-03-06       Impact factor: 3.397

Review 3.  Aspiration and the elderly.

Authors:  M J Feinberg; J Knebl; J Tully; L Segall
Journal:  Dysphagia       Date:  1990       Impact factor: 3.438

Review 4.  The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatment.

Authors:  M A Matthay
Journal:  West J Med       Date:  1989-02

5.  Prandial aspiration and pneumonia in an elderly population followed over 3 years.

Authors:  M J Feinberg; J Knebl; J Tully
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

6.  Association of early antibiotic therapy and in-hospital mortality in adult mild-to-moderate acute aspiration pneumonitis: a cohort study.

Authors:  Masaharu Aga; Toru Naganuma; Yusuke Ohashi; Hiroki Matsuzawa; Suguru Matsuzaka; Ivor Cammack; Gen Yamada; Yoshimoto Serizawa
Journal:  Intern Emerg Med       Date:  2021-03-13       Impact factor: 3.397

7.  An important role of silent aspiration of gastric contents as a cause of pulmonary complications following surgery for esophageal cancer.

Authors:  K Kawasaki; Y Ogawa; Y Kido; T Mori
Journal:  Jpn J Surg       Date:  1987-11

8.  Pulmonary aspiration.

Authors:  J W Little; L H Smith
Journal:  West J Med       Date:  1979-08

9.  Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms.

Authors:  H G Folkesson; M A Matthay; C A Hébert; V C Broaddus
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures.

Authors:  L Mier; D Dreyfuss; B Darchy; J J Lanore; K Djedaïni; P Weber; P Brun; F Coste
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.